Travere Therapeutics, Inc. (TVTX) is a Healthcare company in the Biotechnology industry. It has a market capitalization of $5.68B, a trailing price-to-earnings ratio of 66.2 and a free-cash-flow yield of -0.4%. Over the most recent reported fiscal year, revenue grew 110.5%.